BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

Myeloid cells are showing up everywhere at this year’s AACR conference, suggesting the research community is rapidly expanding the ways it can harness the cell types to improve cancer immunotherapy responses. One of those ways...
BioCentury | May 26, 2016
Distillery Techniques

Techniques: Baculovirus-based vector system for transient, simultaneous expression of multiple genes for genome editing or cellular reprogramming

Drug platforms TECHNOLOGY: Expression systems A baculoviral vector-based system for transient gene expression could be used to develop genome editing- or cellular reprogramming-based therapies. The vector system involved modifying baculovirus by inserting a plasmid containing...
BioCentury | Apr 22, 2010
Distillery Therapeutics

Indication: Cancer

...contact information Cancer Brain cancer Ligase IV, DNA, ATP-dependent (LIG4); BTB domain containing 2 (BTBD2); high mobility group AT-hook 2 (HMGA2)...
...helicase 1 (RTEL1); coiled-coil domain containing 26 (CCDC26) Genetic association studies suggest that LIG4, BTBD2, HMGA2...
...rs10464870, HMGA2 rs891835 and RTEL1 rs2297440 SNPs were associated with longer survival. The LIG4, BTBD2, HMGA2...
BioCentury | Jun 12, 2006
Company News

Oxis sales and marketing update

...to detect and measure high motility group A2 ( HMGA2 ) protein in tissue samples. HMGA2...
Items per page:
1 - 4 of 4